Prostate Cancer

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


WHO WE ARE — Seattle Cancer Care Alliance is a world-class cancer treatment center that unites doctors from Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children's. Learn More

Overview

Prostate cancer can be a complex disease to treat. At Seattle Cancer Care Alliance we use a team approach with physicians from several specialties to determine how to best treat each man’s cancer. Our broad array of treatment options reflects our intensive and successful efforts to maximize cure while minimizing side effects.

Our prostate cancer doctors specialize in prostate cancer and do not treat any other non-genitourinary cancers. Our team of medical oncologists, radiation oncologists, and surgeons work together to provide comprehensive, customized treatments for each patient that will maximize their potential for cure with as few side effects as possible.

Our patients receive state-of-the-art care, including laparoscopic daVinci robotic surgery, an effective, minimally invasive alternative to both open surgery and laparoscopy, and the latest technology to provide the most precise radiation treatment possible using brachytherapy or including special equipment to detect motion and position of the prostate during radiation treatment—the Calypso® System, also referred to as GPS for the Body. Many new drugs or alternative treatments under investigation in clinical studies are available only at SCCA and limited sites around the country.

SCCA received a Specialized Program of Research Excellence (SPORE) grant for our prostate cancer science expertise, which is awarded to only 11 institutions around the country. SCCA also received a Department of Defense Clinical Trials Consortium grant for our clinical studies expertise, which is awarded to only 13 institutions in the U.S. SCCA is one of five institutions with both of these important research grants currently funded, a testament to our expertise and dedication to treating and curing our patients' prostate cancer.